Medicare Enrolled
Dr. Seung-Yil Song, M.D.
Medical Oncology · San Diego, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Song from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Song?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Song
Dr. Seung-Yil Song is a medical oncology specialist in San Diego, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Song performed 52,756 Medicare services across 2,286 unique beneficiaries.
Between the years covered by Open Payments, Dr. Song received a total of $25,168 from 86 pharmaceutical and/or device companies across 1016 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Song is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 10% volume in CA
$25,168 industry payments
Medicare Practice Summary
Medicare Utilization ↗52,756
Medicare services
Top 10% in CA for medical oncology
2,286
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,777 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
28,200 | $0 | $15 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
6,400 | $6 | $100 |
| Injection, granisetron hydrochloride, 100 mcg | 2,746 | $0 | $12 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,006 | $8 | $30 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
1,741 | $6 | $32 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,677 | $0 | $3 |
| Post-glucose dose blood sugar level A blood test to measure glucose levels after a dose of glucose has been administered. |
1,147 | $5 | $20 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,034 | $74 | $130 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
932 | $102 | $150 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
793 | $8 | $10 |
| Central venous tube declotting A procedure to clear a blockage or clot from a central venous catheter to restore its function. |
735 | $30 | $50 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
694 | $49 | $88 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
669 | $94 | $117 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
492 | $12 | $87 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
443 | $25 | $60 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
377 | $119 | $300 |
| Heparin sodium injection, per 1000 units An injection of heparin sodium, a blood thinner, administered in units of 1000. |
339 | $0 | $10 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
299 | $2 | $5 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
264 | $0 | $4 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
251 | $1 | $5 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
244 | $58 | $102 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
140 | $47 | $99 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
108 | $1 | $2 |
| Injection, alteplase recombinant, 1 mg | 107 | $69 | $204 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
106 | $22 | $25 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
105 | $30 | $31 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
81 | $1 | $15 |
| 5% dextrose/water (500 ml = 1 unit) | 79 | $1 | $3 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
78 | $4 | $35 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
74 | $136 | $221 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
67 | $132 | $180 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
66 | $65 | $175 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
50 | $26 | $74 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
42 | $26 | $53 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
41 | $94 | $120 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
33 | $30 | $30 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
32 | $282 | $481 |
| New patient office visit, complex (60-74 min) | 30 | $166 | $250 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
23 | $108 | $240 |
| Stool test for blood to screen for colon tumors A test that analyzes a stool sample to detect hidden blood, which is used to screen for colon tumors. |
11 | $4 | $5 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.6% high complexity
81.8% medium
15.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$25,168
Total received (2018-2024)
Avg $3,595/year across 7 years
Top 27% in CA for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
86
Companies
1,016
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,861 (86.9%)
Other
Charitable contributions, space rental, and other categories
$2,151 (8.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,156 (4.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,979
2023
$3,517
2022
$3,654
2021
$4,008
2020
$2,603
2019
$3,561
2018
$3,845
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,000
SOBI, INC
$326
PFIZER INC.
$302
E.R. Squibb & Sons, L.L.C.
$238
AstraZeneca Pharmaceuticals LP
$218
Alexion Pharmaceuticals, Inc.
$201
Celgene Corporation
$192
Eisai Inc.
$154
Merck Sharp & Dohme LLC
$152
Janssen Biotech, Inc.
$106
Amgen Inc.
$105
PUMA BIOTECHNOLOGY, INC.
$72
Lilly USA, LLC
$65
Rigel Pharmaceuticals, Inc.
$65
Gilead Sciences, Inc.
$63
Takeda Pharmaceuticals U.S.A., Inc.
$60
Bayer Healthcare Pharmaceuticals Inc.
$49
Agios Pharmaceuticals, Inc.
$49
Ipsen Biopharmaceuticals, Inc
$44
INTUITIVE SURGICAL, INC.
$44
Incyte Corporation
$41
GENZYME CORPORATION
$41
Exelixis Inc.
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$31
Coherus Biosciences Inc.
$30
Genentech USA, Inc.
$29
BeiGene USA, Inc.
$28
PharmaEssentia USA Corporation
$27
Mirati Therapeutics, Inc.
$27
Regeneron Healthcare Solutions, Inc.
$26
Amneal Pharmaceuticals LLC
$26
Octapharma USA, Inc.
$24
Blueprint Medicines Corporation
$23
Daiichi Sankyo Inc.
$22
Kite Pharma, Inc.
$21
Pharmacosmos Therapeutics Inc.
$20
ARRAY BIOPHARMA INC
$20
Top 3 companies account for 40.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$3,774
Merck Sharp & Dohme Corporation
$1,752
E.R. Squibb & Sons, L.L.C.
$1,654
Amgen Inc.
$1,401
PFIZER INC.
$1,219
AstraZeneca Pharmaceuticals LP
$1,097
Alexion Pharmaceuticals, Inc.
$1,065
Janssen Biotech, Inc.
$962
Celgene Corporation
$686
Seagen Inc.
$611
Genentech USA, Inc.
$582
Lilly USA, LLC
$545
Incyte Corporation
$491
SOBI, INC
$489
Merck Sharp & Dohme LLC
$473
Astellas Pharma US Inc
$423
Eisai Inc.
$414
Takeda Pharmaceuticals U.S.A., Inc.
$377
Rigel Pharmaceuticals, Inc.
$299
GlaxoSmithKline, LLC.
$281
Kite Pharma, Inc.
$276
PUMA BIOTECHNOLOGY, INC.
$255
Boehringer Ingelheim Pharmaceuticals, Inc.
$255
NOVARTIS PHARMACEUTICALS CORPORATION
$250
GENZYME CORPORATION
$237
Bayer HealthCare Pharmaceuticals Inc.
$230
Blueprint Medicines Corporation
$220
Ipsen Biopharmaceuticals, Inc
$194
Gilead Sciences, Inc.
$187
Puma Biotechnology, Inc.
$182
ARRAY BIOPHARMA INC
$166
Karyopharm Therapeutics Inc.
$163
Regeneron Healthcare Solutions, Inc.
$162
EMD Serono, Inc.
$157
Daiichi Sankyo Inc.
$153
EISAI INC.
$153
Bayer Healthcare Pharmaceuticals Inc.
$153
Aurobindo Pharma USA, Inc.
$151
Exelixis Inc.
$135
Sobi, Inc
$135
Taiho Oncology, Inc.
$130
Emmaus Medical, Inc.
$129
TESARO, Inc.
$125
PharmaEssentia USA Corporation
$124
AbbVie, Inc.
$122
Mirati Therapeutics, Inc.
$120
Pharmacyclics LLC, an AbbVie Company
$116
Dova Pharmaceuticals
$106
Foundation Medicine, Inc.
$102
Seattle Genetics, Inc.
$101
Janssen Scientific Affairs, LLC
$96
Pharmacyclics LLC, An AbbVie Company
$93
BeiGene USA, Inc.
$84
Helsinn Therapeutics (U.S.), Inc.
$83
Stemline Therapeutics Inc.
$80
Epizyme, Inc.,
$79
Global Blood Therapeutics, Inc.
$75
Heron Therapeutics, Inc.
$66
JAZZ PHARMACEUTICALS INC.
$65
Acrotech Biopharma LLC
$64
Sirtex Medical Inc
$53
EUSA Pharma (US) LLC
$50
Janssen Pharmaceuticals, Inc
$49
Agios Pharmaceuticals, Inc.
$49
Amneal Pharmaceuticals LLC
$44
INTUITIVE SURGICAL, INC.
$44
ADC Therapeutics America, Inc.
$42
Octapharma USA, Inc.
$41
Clovis Oncology, Inc.
$40
MEDIVATION FIELD SOLUTIONS LLC
$34
Terumo BCT, Inc.
$33
Coherus Biosciences Inc.
$30
TAIHO ONCOLOGY, INC.
$29
Sun Pharmaceutical Industries Inc.
$27
Deciphera Pharmaceuticals Inc.
$24
Spectrum Pharmaceuticals Inc.
$24
Teva Pharmaceuticals USA, Inc.
$23
Myriad Genetic Laboratories, Inc.
$23
Myovant Sciences Inc.
$22
ImmunoGen, Inc.
$21
Pharmacosmos Therapeutics Inc.
$20
MACROGENICS, INC.
$18
Ferring Pharmaceuticals Inc.
$17
Mylan Institutional Inc.
$16
TerSera Therapeutics LLC
$14
Fortovia Therapeutics, Inc.
$11
Top 3 companies account for 28.5% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AKYNZEO · ALIMTA · ALOXI · ALUNBRIG · AVASTIN · AYVAKIT · Abraxane · Alecensa · Avastin · BALVERSA · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Beleodaq · Blincyto · CABOMETYX · CALQUENCE · CINVANTI · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELIQUIS · ELREXFIO · ELZONRIS · EMEND · EMPLICITI · ERBITUX · ERLEADA · Elahere · Endari · Enhertu · FIRMAGON · FLULAVAL · FOLOTYN · FOUNDATIONONE · Folotyn · GAMIFANT · GAVRETO · GAZYVA · GILOTRIF · Gamifant · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · Imbruvica · Inrebic · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LOQTORZI · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MARGENZA · MEKINIST · MONJUVI · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Ogivri · Onivyde · PADCEV · PEMAZYRE · PIQRAY · PREVNAR 20 · PROMACTA · PYRUKYND · Perjeta · Polivy · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Rezlidhia · Rubraca · SARCLISA · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · Soliris · Somatuline Depot · Spectra Optia Apheresis System · Stivarga · Sustol · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIVDAK · TRUMENBA · TUKYSA · Tavalisse · Tazverik · Trodelvy · Truxima · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · YERVOY · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYKADIA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Medical oncologists within 10 mi
18
Per 100K population
0.5
County median income
$102,285
Nearest hospital
SHARP MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Song is a mixed practice specialist, with above-average Medicare volume (top 10% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Song experienced with filgrastim injection (nivestym) for white blood cells?
Based on Medicare claims data, Dr. Song performed 28,200 filgrastim injection (nivestym) for white blood cells services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Song receive payments from pharmaceutical companies?
Yes. Dr. Song received a total of $25,168 from 86 companies across 1,016 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Song's costs compare to other medical oncologists in San Diego?
Dr. Song's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Song) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in San Diego
Browse medical oncologists in San Diego ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in CA
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in CA
Which CA medical oncologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology